Results 141 to 150 of about 14,712 (219)
Drug Development Research, Volume 86, Issue 4, June 2025.ABSTRACT Tuberculosis (TB) is considered a major infectious disease by the World Health Organization. The WHO estimates that there are 1.8 million TB deaths, and 10.4 million new cases of the disease reported yearly. While there are conventional therapies for TB, they have drawbacks such as a lengthy pill regimen, rigorous scheduling, and protracted ...
Nnamdi Ikemefuna Okafor +3 more
wiley +1 more source
FLUOROQUINOLONES AND ACHILLES TENDINOPATHY IN RENAL TRANSPLANT RECIPIENTS
, 1994 JAN B. DONCK +2 more
openalex +1 more source
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli [PDF]
, 1996 Peter Heisig
openalex +1 more source
Muscle &Nerve, Volume 71, Issue 6, Page 1063-1071, June 2025.ABSTRACT Introduction/Aims The true frequency and severity of myasthenia gravis (MG) exacerbation associated with the usage of fluoroquinolone and macrolide antibiotics remain unknown. We aimed to investigate the association between ciprofloxacin, levofloxacin, azithromycin, and MG exacerbation.
Sanem Pinar Uysal +3 more
wiley +1 more source
Pharmacoepidemiology and Drug Safety, Volume 34, Issue 6, June 2025.ABSTRACT Background Ceftriaxone is believed to increase the risk of biliary infections due to pseudolithiasis caused by ceftriaxone‐calcium precipitation, but this risk is not well understood. This study aimed to investigate whether ceftriaxone use is associated with an increased risk of biliary infections in pneumonia patients using a national ...
Jumpei Taniguchi +4 more
wiley +1 more source
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent
, 1990 George M. Eliopoulos +4 more
openalex +1 more source
The New Fluoroquinolones: A Critical Review [PDF]
, 1999 George G. Zhanel +6 more
openalex +1 more source
Pharmacology Research &Perspectives, Volume 13, Issue 3, June 2025.ABSTRACT We report findings from three SCCS conducted to quantify the association between fluoroquinolone (FQ) use for the treatment of uncomplicated urinary tract infection (uUTI) and tendon rupture, retinal detachment, and uveitis. Female patients aged ≥ 12 years old in the Optum Clinformatics Data Mart database with an outcome of interest and ...
Anna Schultze +5 more
wiley +1 more source
Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile [PDF]
The Lancet Infectious Diseases, 2017 Curtis J. Donskey, Curtis J. Donskey
openaire +3 more sources